Tuberculosis is an active infection in the body that predominately affects the lungs. It has gone by many names but "consumption" and "TB" have been the most prevalent names for the condition since the late 1800s.
According to Merriam-Webster, phthisiology is "the care, treatment, and study of tuberculosis."
The Red Cross remained a sponsor of the Christmas Seals through 1919. Sponsorship of the campaign was then transferred to the National Tuberculosis Association (which later evolved into the American Lung Association.)
Dr. Hall was a former Acting Assistant Surgeon of the USA, a member of the International Tuberculosis Congress, and the National Association for the Study and Prevention of Tuberculosis.
After it was discovered that bacteria could survive in spittle on the streets and sidewalks, hem lengths on women's dresses (previously floor length) were shortened to avoid contamination.
Heliotherapy is defined as "the systematic exposure of the nude body to the rays of the sun for treatment purposes." The advantage of the sun was said to be the blending of all ranges of radiation. A portion of the school day in the early part of the century, continuing into the 1930s, was taking school children outdoors and exposing them to the sun, as seen here. Heliotherapy remained an important part of treatment for tuberculosis well into the 1940s.
The san closed in the mid 1970s. Lutheran Hospital, Moline IL was then the designated treatment site, with a 6 bed in- patient unit for individuals with active TB.
This photo was taken in 1937 at a TB Sanitarium near Peoria, Illinois.
This photo was taken of residents in a high school class of at a TB san near Peoria, Illinois in 1937.
They filed a patent application for "Streptomycin and Process of Preparation" in February 1945 and were awarded the patent on September 21, 1948.
Waksman was awarded a Novel prize in 1952.
The ad from 1950 also stated that the likelihood of developing TB is greatly reduced by getting plenty of sleep, rest, proper exercise, and nourishing food.
MDR-TB results from an organism that is resistant to at least isoniazid and rifampin, the two most potent TB drugs.
XDR-TB is resistant to isoniazid and rifampin, any fluoroquinolone, and one or more of the second-line drugs (such as capreomycin, amikacin, or kanamycin).
Anti-TB drug resistance primarily occurs when patients do not complete their full course of treatment or when health-care providers prescribe the incorrect drug combinations, wrong duration, or incorrect dose.